AHAG yields 2000000.00% · PFE yields 6.13%● Live data
📍 AHAG pulled ahead of the other in Year 1
Combined, AHAG + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHAG + PFE for your $10,000?
Alpha Technologies Group, Inc., through its subsidiaries, manufactures, fabricates, and sells thermal management and non-thermal fabricated products, and aluminum extrusions in the United States. It offers natural convection products, which include thermal extrusions, board level and BGA heatsinks, LED heat sinks, folded fins, bonded and stacked fins, and heat frames; forced convection products, such as skived and zipper fins, and fans; fluid phase change products, including heat pipes; and liquid cooling products, such as liquid cold plates, heat exchangers, and coolant distribution units. The company also provides accessories, such as wedgelocks, front panels, enclosures, precision clamps, thermal interface material, and data center cooling accessories; and universal joints, which include alves blue blocks, solid blocks, hex blocks, double universal joints, needle bearings, and universal joint accessories. In addition, it offers engineering, such as applications engineering and design services; manufacturing, which include extrusion, fabrication, machining services, and quick turn prototyping; supply chain services; and data center cooling services. It serves aerospace/defense, architecture, power conversion, information tech, renewable energy, telecommunications, led lighting, factory automation, consumer, medical, and transportation industries; and construction, sporting goods, and other leisure activity markets. Alpha Technologies Group, Inc. was formerly known as Synercom Technology, Inc. and changed its name to Alpha Technologies Group, Inc. in 1995. The company was founded in 1969 and is based in Los Angeles, California.
Full AHAG Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.